SCOTT KENSLOW: Open Payments
NPI 1710427521 · WEST PLAINS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 12 payments from 7 companies in 2025. Trend: 2023 $457 · 2024 $392 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $139 |
| Genentech USA, Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| RxSight Inc | 1 | $19 |
| Sight Sciences, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Alcon Vision LLC | 1 | $17 |
Products named: DURYSTA, QULIPTA, Vabysmo, ILUVIEN, RXSIGHT INJECTOR HANDPIECE, OMNI SURGICAL SYSTEM, ACTHAR, HYDRUS Microstent.
Industry payments across MO — which companies pay providers there.
